Madrigal Pharmaceuticals, Inc. (MDGL)
543.91
+5.03
(+0.93%)
USD |
NASDAQ |
Aug 27, 16:00
543.91
0.00 (0.00%)
After-Hours: 20:00
Madrigal Pharmaceuticals EPS Diluted (TTM) : -12.88 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.88 |
| March 31, 2026 | -12.80 |
| December 31, 2025 | -12.86 |
| September 30, 2025 | -13.01 |
| June 30, 2025 | -12.85 |
| March 31, 2025 | -18.04 |
| December 31, 2024 | -22.11 |
| September 30, 2024 | -25.07 |
| June 30, 2024 | -25.50 |
| March 31, 2024 | -23.08 |
| December 31, 2023 | -19.94 |
| September 30, 2023 | -19.24 |
| June 30, 2023 | -18.64 |
| March 31, 2023 | -18.09 |
| December 31, 2022 | -17.23 |
| September 30, 2022 | -16.03 |
| June 30, 2022 | -15.07 |
| March 31, 2022 | -14.66 |
| December 31, 2021 | -14.61 |
| September 30, 2021 | -14.65 |
| June 30, 2021 | -14.61 |
| March 31, 2021 | -14.07 |
| December 31, 2020 | -13.09 |
| September 30, 2020 | -11.07 |
| June 30, 2020 | -8.706 |
| Date | Value |
|---|---|
| March 31, 2020 | -6.812 |
| December 31, 2019 | -5.451 |
| September 30, 2019 | -4.401 |
| June 30, 2019 | -3.567 |
| March 31, 2019 | -2.735 |
| December 31, 2018 | -2.204 |
| September 30, 2018 | -2.126 |
| June 30, 2018 | -2.250 |
| March 31, 2018 | -2.490 |
| December 31, 2017 | -2.54 |
| September 30, 2017 | -2.518 |
| June 30, 2017 | -3.178 |
| March 31, 2017 | -574.04 |
| December 31, 2016 | -913.74 |
| September 30, 2016 | -1287.17 |
| June 30, 2016 | -1294.58 |
| March 31, 2016 | -728.28 |
| December 31, 2015 | -394.73 |
| September 30, 2015 | -27.30 |
| June 30, 2015 | -25.20 |
| March 31, 2015 | -28.35 |
| December 31, 2014 | -31.50 |
| September 30, 2014 | -35.70 |
| June 30, 2014 | -40.60 |
| March 31, 2014 | -43.75 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Insmed, Inc. | -4.105 |
| PTC Therapeutics, Inc. | -0.5938 |
| Protagonist Therapeutics, Inc. | 1.037 |
| Exelixis, Inc. | 3.184 |
| Karyopharm Therapeutics, Inc. | -13.08 |